Scientific Reports

Table 1 Characteristics of 389 intrahepatic cholangiocarcinoma patients.

From: A novel model for predicting the prognosis of postoperative intrahepatic cholangiocarcinoma patients

	Patients	IIPI				p value
	Patients	None	Light	Moderate	Severe	p value
Total patients	389	79	155	93	62
Age (years)						0.020
> 60.0	176	31	77	49	19
≤ 60.0	213	48	78	44	43
Gender						0.779
Male	189	38	80	42	29
Female	200	41	75	51	33
HBV status						0.003
Positive	96	30	41	14	11
Negative	293	49	114	79	51
Number of lesions						0.084
Multiple	102	13	48	22	19
Single	287	66	107	71	43
MVI						0.531
Positive	46	6	22	11	7
Negative	343	73	133	82	55
TNM staging						0.101
I/II	95	25	42	17	11
III/IV	294	54	113	76	51
Cirrhosis						0.758
Positive	37	8	17	8	4
Negative	352	71	138	85	58
Differentiation						0.204
Medium/high	105	28	35	24	18
Poor	284	51	120	69	44
AFP (ng/ml)						0.120
> 7.0	50	9	24	6	11
≤ 7.0	339	70	131	87	51
CA199 (u/ml)						0.000
> 30.0	280	42	94	82	62
≤ 30.0	109	37	61	11	0
CEA (ng/ml)						0.000
> 5.0	169	3	46	58	62
≤ 5.0	220	76	109	35	0
dNLR						0.000
> 2.63	228	3	101	68	56
≤ 2.63	161	76	54	25	6
NLR						0.000
> 1.77	252	0	118	72	62
≤ 1.77	137	79	37	21	0
LDH						0.053
> 250	55	6	23	13	13
≤ 250	324	73	132	80	39
LMR						0.000
> 4.1	145	50	53	26	16
≤ 4.1	244	29	102	67	46

HBV, hepatitis B virus; MVI, microvascular invasion; TNM, Tumor Node Metastasis; AFP, α-fetoprotein; CA199, Carbohydrate antigen199; CEA, carcinoembryonic antigen; dNLR, derived neutrophil-to-lymphocyte ratio; LDH, lactate dehydrogenase; LMR, lymphocyte-monocyte ratio.

Back to article page

Search

Advanced search

Quick links